Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
72.94
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
These three stocks have two important common denominators: the same industry and tremendous growth prospects.
Via
The Motley Fool
Got $200? 2 Dividend Stocks to Buy and Hold Forever
March 01, 2024
Trust these two real estate stocks to be attractively priced and proven performers.
Via
The Motley Fool
This Is What Whales Are Betting On Moderna
February 29, 2024
Via
Benzinga
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
The futures for these two beaten-down stocks could be brighter than their recent pasts.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
February 28, 2024
Via
Benzinga
Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short
February 28, 2024
Watch these companies, whose share prices have seen big swings higher or lower after they reported Q4 2023 earnings.
Via
InvestorPlace
Where Moderna Stands With Analysts
February 23, 2024
Via
Benzinga
Why Moderna Stock Is Jumping Today
February 22, 2024
The biotech company surprised investors with a Q4 profit.
Via
The Motley Fool
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
February 28, 2024
When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track...
Via
Benzinga
Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
February 28, 2024
A lot is riding on whether there will be demand for its new vaccines.
Via
The Motley Fool
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Block To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Monday
February 26, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Peering Into Moderna's Recent Short Interest
February 20, 2024
Via
Benzinga
Moderna's Options: A Look at What the Big Money is Thinking
February 14, 2024
Via
Benzinga
Moderna (MRNA) Q4 2023 Earnings Call Transcript
February 22, 2024
MRNA earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Posts Quarterly Profit Despite Lower Sales From COVID-19 Vaccine
February 22, 2024
Moderna reports Q4 2023 revenues of $2.81 billion from Spikevax (COVID-19 vaccine), exceeding expectations.
Via
Benzinga
Exposures
COVID-19
Moderna’s Unexpected $217 Million Profit Marks A Surprising Q4 Achievement
February 22, 2024
Moderna Inc. showcased a resilient fourth-quarter performance for the fiscal year 2023, navigating through the challenges posed by the transition to an endemic market environment.
Via
Talk Markets
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Range-Bound Moderna Could Get A Boost On Its Fourth-Quarter Report
February 22, 2024
The company unexpectedly came in with fourth-quarter earnings that beat projections.
Via
Investor's Business Daily
Moderna Likely To Report Q4 Loss; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 22, 2024
Moderna, Inc. (NASDAQ: MRNA) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 22, 2024.
Via
Benzinga
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Via
Benzinga
Exposures
COVID-19
Product Safety
Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.
February 19, 2024
Layoffs were a big theme in 2023. Unless the economy drastically picks up in 2024, they could happen this year in large numbers.
Via
InvestorPlace
Topics
Economy
Workforce
Exposures
Economy
Layoff
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
To Sell or Not to Sell: How to Handle the Inevitable Nvidia Downturn
February 15, 2024
The NVDA stock outlook is complex, because there's a correction coming, and you don't want to be in it when it does.
Via
InvestorPlace
ChatGPT Stock Predictions: 3 Companies the AI Bot Thinks Have 10X Potential
February 14, 2024
Navigate the stock market with confidence using AI stock predictions. Harness the latest in AI technology for strategic investment planning.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Stocks Down 36% or More to Buy and Hold for 10 Years
February 13, 2024
These companies have seen better days.
Via
The Motley Fool
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.
Via
InvestorPlace
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.